Journal article

Short-course rapamycin treatment enables engraftment of immunogenic gene-engineered bone marrow under low-dose irradiation to permit long-term immunological tolerance

Kunal H Bhatt, Rajeev Rudraraju, Jeremy F Brooks, Ji-Won Jung, Ryan Galea, James W Wells, Raymond J Steptoe

STEM CELL RESEARCH & THERAPY | BIOMED CENTRAL LTD | Published : 2017

University of Melbourne Researchers

Grants

Awarded by NHMRC


Awarded by Australian Research Council Future Fellowship


Awarded by Australian Research Council


Funding Acknowledgements

This work was supported by NHMRC Project Grant GNT1013066 (RJS). KHB was supported by a UQ Postdoctoral Fellowship. RJS was a recipient of Australian Research Council Future Fellowship (FT110100372). JWW was supported in part by grants from the Australian Research Council (DP150103714) and by a Perpetual Trustees Fellowship.